Significantly Lower CYP2D6 Metabolism Measured as the O/N -Desmethylvenlafaxine Metabolic Ratio in Carriers of CYP2D6*41 Versus CYP2D6*9 or CYP2D6*10 - A Study on Therapeutic Drug Monitoring Data From 1,003 Genotyped Scandinavian Patients

British Journal of Clinical Pharmacology - United Kingdom

doi 10.1111/bcp.13788